Gabapentin Capsule
Product Images NDC 42582-115

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 42582-115). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bi-coastal Pharma International Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cockcroft And Gault Equation (Image 04)

An illustration showing a formula to calculate creatinine clearance (CLCr) based on age, weight, and serum creatinine, with an adjustment factor for female patients. The formula is displayed in a mathematical equation format.*

FDA Label Image

Gabapentin Structural Formula (Image 05)

Chemical structure of Gabapentin showing its molecular framework including an amino group (NH2), a carboxylic acid group (COOH), and a cyclohexane ring.*

FDA Label Image

Figure 1. Weekly Mean Pain Scores (observed Cases In Itt Population): Study 1 (Image 06)

A line graph showing mean pain scores over an 8-week period comparing placebo and Gabapentin 3600 mg/day. The x-axis represents weeks from baseline to week 8, and the y-axis shows mean pain scores ranging from 0 to 10. The graph includes a 4-week dose titration period followed by a 4-week fixed dose period, with Gabapentin showing a decreasing trend in pain scores compared to placebo.*

FDA Label Image

Figure 2. Weekly Mean Pain Scores (observed Cases In Itt Population): Study 2 (Image 07)

A line graph depicting mean pain scores over 7 weeks for three groups: placebo, gabapentin 1800 mg/day, and gabapentin 2400 mg/day. The x-axis represents time in weeks, and the y-axis shows mean pain scores from 0 to 10. The graph includes a 3-week dose titration period followed by a 4-week fixed dose period, illustrating decreasing pain scores in gabapentin groups compared to placebo.*

FDA Label Image

Figure 3. Proportion Of Responders (patients With ≥ 50% Reduction In Pain Score) At Endpoint: Controlled Phn Studies (Image 08)

A bar chart showing results of two studies labeled Study 1 and Study 2. The y-axis represents percentages from 0% to 100%. Study 1 compares PBO (placebo) at 12% to GBP 3600 at 29%. Study 2 compares PBO at 14% to GBP 1800 at 32% and GBP 2400 at 34%. Statistical significance is indicated with ** for p < 0.01 and *** for p < 0.001 above respective bars.*

FDA Label Image

Figure 4. Responder Rate In Patients Receiving Gabapentin Expressed As A Difference From Placebo By Dose And Study: Adjuctive Therapy Studies In Patients Greater Than Or Equal To 12 Years Of Age With Partial Seizures (Image 09)

A scatter plot comparing differences in percentage across three studies labeled a, b, and c, with daily dose (mg) on the x-axis ranging approximately from 600 to 1800 mg. The y-axis shows difference percentage from 2% to 22%. Study a is represented by black squares, study b by shaded squares, and study c by white squares.*

FDA Label Image

Image Description (Label 100mg)

Label for Gabapentin Capsules USP 100 mg by Bi-Coastal Pharma International LLC. The label shows the product name and strength, indicates 100 capsules per container, and includes storage instructions. Distributor and manufacturer information are also present, along with a barcode and placeholders for lot number and expiration date.*

FDA Label Image

Image Description (Label 300mg)

Gabapentin Capsules, USP 300 mg oral capsules label by Bi-Coastal Pharma International LLC. The label indicates the product contains 100 capsules and is for prescription use only. It includes storage instructions and distributor and manufacturer information, along with a barcode and space for lot number and expiration date.*

FDA Label Image

Image Description (Label 400mg)

Gabapentin Capsules USP 400 mg label from Bi-Coastal Pharma International LLC. The label states the capsules contain 400 mg of gabapentin, available as 100 capsules per container. Instructions include storage temperature and dispensing in a well-closed container. Manufactured by Marksans Pharma Ltd. in India, distributed by Bi-Coastal Pharma International in New Jersey.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.